University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

It is unprecedented : trial management during the COVID-19 pandemic and beyond

Simple item page
dc.contributor.authorMitchell, Eleanor J
dc.contributor.authorAhmed, Khaled
dc.contributor.authorBreeman, Suzanne
dc.contributor.authorCotton, Seonaidh
dc.contributor.authorConstable, Lynda
dc.contributor.authorFerry, Gillian
dc.contributor.authorGoodman , Kirsteen
dc.contributor.authorHickey, Helen
dc.contributor.authorMeakin, Garry
dc.contributor.authorMironov, Katy
dc.contributor.authorQuann, Niamh
dc.contributor.authorWakefield, Natalie
dc.contributor.authorMcDonald, Alison
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Evaluationen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2020-09-15T15:57:00Z
dc.date.available2020-09-15T15:57:00Z
dc.date.issued2020-09-11
dc.descriptionFunding: UKTMN is funded by the Nuffield Department of Population Health (NDPH) at the University of Oxford. Acknowledgments: We thank Graeme MacLennan, Director of the Centre for Health Care Randomised Trials (CHaRT) for the inspiration for this article and UKTMN members for their input into its content. We also thank the huge clinical trial community, both nationally and internationally, for continuing to run clinical trials in these challenging times, and for regulatory agencies to adapting their processes to enable efficiencies.en
dc.description.statusPeer revieweden
dc.format.extent7
dc.format.extent522498
dc.identifier175082728
dc.identifier34f7115e-f571-43fb-88ce-b38c40e90765
dc.identifier85090903048
dc.identifier32917258
dc.identifier.citationMitchell, E J, Ahmed, K, Breeman, S, Cotton, S, Constable, L, Ferry, G, Goodman , K, Hickey, H, Meakin, G, Mironov, K, Quann, N, Wakefield, N & McDonald, A 2020, 'It is unprecedented : trial management during the COVID-19 pandemic and beyond', Trials, vol. 21, 784, pp. 784. https://doi.org/10.1186/s13063-020-04711-6en
dc.identifier.doi10.1186/s13063-020-04711-6
dc.identifier.issn1745-6215
dc.identifier.otherORCID: /0000-0001-9646-3904/work/93483378
dc.identifier.urihttps://hdl.handle.net/2164/15134
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85090903048&partnerID=8YFLogxKen
dc.identifier.vol21en
dc.language.isoeng
dc.relation.ispartofTrialsen
dc.subjectCOVID-19en
dc.subjectpandemicen
dc.subjectclinical trialen
dc.subjectTrial managementen
dc.subjectClinical trialen
dc.subjectPandemicen
dc.subjectBetacoronavirus/pathogenicityen
dc.subjectPandemicsen
dc.subjectData Accuracyen
dc.subjectRisk Assessmenten
dc.subjectHumansen
dc.subjectRisk Factorsen
dc.subjectWorkflowen
dc.subjectData Collectionen
dc.subjectCoronavirus Infections/diagnosisen
dc.subjectHost-Pathogen Interactionsen
dc.subjectClinical Trials Data Monitoring Committeesen
dc.subjectTime Factorsen
dc.subjectPatient Safetyen
dc.subjectClinical Trials as Topic/methodsen
dc.subjectResearch Designen
dc.subjectPneumonia, Viral/diagnosisen
dc.subjectR Medicineen
dc.subjectPharmacology (medical)en
dc.subjectMedicine (miscellaneous)en
dc.subject.lccRen
dc.titleIt is unprecedented : trial management during the COVID-19 pandemic and beyonden
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Mitchell_et_al_TRL_ItIsUnprecedent_VoR.pdf
Size:
510.25 KB
Format:
Adobe Portable Document Format
Download

Collections

All research